Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster

NCT05465902 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Clinical trials not conducted

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: Recombinant COVID-19 variant Vaccine (Sf9 Cell)
BIOLOGICAL: COVID-19 Vaccine (Vero Cell), Inactivated
BIOLOGICAL: mRNA COVID-19 vaccine (Moderna)
BIOLOGICAL: Viral Vector COVID-19 vaccine (AstraZeneca)

Sponsor

WestVac Biopharma Co., Ltd.